Clincosm LogoSign in Get a demo

plasma cell neoplasm

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

Completed
Has Results
  • Myelodysplastic Syndrome
  • +13 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022

Advanced Cancer, Ovarian Cancer, Lung Cancer Trial in United States (Dose escalation: COM902 monotherapy., Evaluation of

Recruiting
  • Advanced Cancer
  • +6 more
  • Dose escalation: COM902 monotherapy.
  • +3 more
  • Grand Rapids, Michigan
  • +5 more
Aug 8, 2022

Multiple Myeloma, Plasma Cell Tumor, Malignant Plasma Cell Tumor Trial in Houston (Radiation Therapy)

Recruiting
  • Multiple Myeloma
  • +2 more
  • Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Plasma Cell Tumor Trial in Atlanta (Pneumococcal 13-valent Conjugate Vaccine, Trivalent Influenza Vaccine)

Active, not recruiting
  • Plasma Cell Neoplasm
  • Pneumococcal 13-valent Conjugate Vaccine
  • Trivalent Influenza Vaccine
  • Atlanta, Georgia
  • +1 more
Jan 24, 2022

Multiple Myeloma, Plasma Cell Tumor Trial in Columbus (lenalidomide, vorinostat)

Completed
  • Multiple Myeloma
  • Plasma Cell Neoplasm
  • Columbus, Ohio
    Ohio State University
May 14, 2020

Kidney Cancer, Leukemia, Lymphoma Trial in Minneapolis (biological, drug, procedure, radiation)

Terminated
Has Results
  • Kidney Cancer
  • +5 more
  • anti-thymocyte globulin
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Apr 29, 2020

Multiple Myeloma, Plasma Cell Tumor Trial in Tampa (etoposide phosphate, melphalan, topotecan)

Completed
  • Multiple Myeloma
  • Plasma Cell Neoplasm
  • etoposide phosphate
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 6, 2019

S0702: Osteonecrosis of Jaw in Cancer Receiving Zoledronic Acid

Completed
  • Breast Cancer
  • +6 more
  • assessment of therapy complications
  • Anniston, Alabama
  • +452 more
Jul 3, 2019

Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Primary Cutaneous Follicle Centre Lymphoma Trial in Hefei (Autologous

Unknown status
  • Diffuse Large B Cell Lymphoma
  • +6 more
  • Autologous chimeric antigen receptor T cell transfusing agent targeting CD22
  • Hefei, Anhui, China
    PersonGen·Anke cellular therapeutics Co., Ltd
Jun 25, 2019

Multiple Myeloma, Plasma Cell Tumor Trial in United States (Lenalidomide, Dexamethasone, Anticoagulants)

Terminated
Has Results
  • Multiple Myeloma
  • Plasma Cell Neoplasm
  • Scottsdale, Arizona
  • +15 more
Sep 22, 2018

Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, Adult Burkitt Lymphoma Trial in Winston-Salem (cefepime HCl)

Completed
  • Adult Acute Lymphoblastic Leukemia
  • +38 more
  • cefepime hydrochloride
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 16, 2018

Anemia, Multiple Myeloma, Plasma Cell Tumor Trial in Cleveland (epoetin alfa)

Completed
Has Results
  • Anemia
  • +2 more
  • epoetin alfa
  • Cleveland, Ohio
    Case Comprehensive Cancer Center
Jan 24, 2018

Leukemia, Lymphoma, Multiple Myeloma Trial in Minneapolis (biological, drug, radiation)

Completed
  • Leukemia
  • +4 more
  • umbilical cord blood transplantation
  • +6 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 29, 2017

Multiple Myeloma, Plasma Cell Tumor Trial in Boston (biological, drug, procedure)

Terminated
Has Results
  • Multiple Myeloma
  • Plasma Cell Neoplasm
  • filgrastim
  • +3 more
  • Boston, Massachusetts
    Boston University Cancer Research Center
Dec 2, 2016

Thrombosis in Newly Diagnosed Multiple Myeloma Receiving

Completed
  • Multiple Myeloma
  • +2 more
  • enzyme-linked immunosorbent assay
  • +2 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Aug 18, 2016

Multiple Myeloma, Plasma Cell Tumor Trial in United States (filgrastim, CD34+ cells, cyclophosphamide)

Completed
  • Multiple Myeloma
  • Plasma Cell Neoplasm
  • filgrastim
  • +6 more
  • San Francisco, California
  • +14 more
Jul 1, 2016

Leukemia, Lymphoma, Multiple Myeloma Trial in United States (biological, drug, procedure)

Completed
  • Leukemia
  • +5 more
  • anti-thymocyte globulin
  • +8 more
  • La Jolla, California
  • +11 more
Jun 30, 2016

Multiple Myeloma, Plasma Cell Tumor Trial in Royal Oak, Salt Lake City (dexamethasone, lenalidomide, )

Completed
Has Results
  • Multiple Myeloma
  • Plasma Cell Neoplasm
  • Royal Oak, Michigan
  • +1 more
Mar 5, 2015

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Plasma Cell Tumor Trial in Belgium, Russian Federation,

Completed
  • Monoclonal Gammopathy of Undetermined Significance
  • +2 more
  • Siltuximab
  • Chicago, Illinois
  • +7 more
Jan 16, 2015

Leukemia, Lymphoma, Multiple Myeloma Trial in United States (human myeloid progenitor cells)

Completed
  • Leukemia
  • +4 more
  • human myeloid progenitor cells
  • Orange, California
  • +7 more
Oct 23, 2014

Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +84 more
  • sunitinib malate
  • +2 more
  • Los Angeles, California
  • +10 more
Mar 14, 2014

Multiple Myeloma, Plasma Cell Tumor Trial in Knoxville, Powell (Human immune globulin intravenous (IGIV))

Completed
Has Results
  • Multiple Myeloma
  • Plasma Cell Neoplasm
  • Human immune globulin intravenous (IGIV)
  • Knoxville, Tennessee
  • +1 more
Sep 16, 2013

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Withdrawn
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +102 more
  • management of therapy complications
  • musculoskeletal complications management/prevention
  • (no location specified)
Jul 5, 2012

Multiple Myeloma, Plasma Cell Tumor Trial in Seattle (chemoprotection, complementary or alternative medicine procedure,

Completed
  • Multiple Myeloma
  • Plasma Cell Neoplasm
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center
Aug 30, 2011